Simian varicella virus reactivation in cynomolgus monkeys

Virology

Volumn 368, Issue 1, 2007, Pages 50-59

  Mahalingam, Ravi ^a   Traina Dorge, Vicki ^b   Wellish, Mary ^a   Lorino, Rebecca ^b   Sanford, Robert ^c   Ribka, Erin P ^b   Alleman, Scott J ^c   Brazeau, Elizabeth ^a   Gilden, Donald H ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^c TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Simian varicella virus reactivation

Indexed keywords

GLYCOPROTEIN; PREDNISONE; TACROLIMUS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHICKENPOX; CONTROLLED STUDY; DNA ISOLATION; GANGLION; IMMUNOSUPPRESSIVE TREATMENT; LUNG; MONKEY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RNA ISOLATION; SIMIAN VARICELLA VIRUS; SKIN; STRESS; VARICELLA ZOSTER VIRUS; VIRUS LATENCY; VIRUS REACTIVATION; X IRRADIATION;

ANIMALS; CHICKENPOX; DNA, VIRAL; GANGLIA; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LUNG; MACACA FASCICULARIS; PREDNISONE; RNA, VIRAL; SKIN; STRESS, PSYCHOLOGICAL; TACROLIMUS; VARICELLOVIRUS; VIRUS ACTIVATION; X-RAYS;

CERCOPITHECINE HERPESVIRUS 9; HUMAN HERPESVIRUS 3; MACACA FASCICULARIS; PRIMATES; SAL VIEJA VIRUS;

EID: 35348937120     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2007.06.025     Document Type: Article

References (38)

1. Abendroth A., and Arvin A.M. Immune evasion as a pathogenic mechanism of varicella zoster virus. Semin. Immunol. 13 1 (2001) 27-39
2. Annunziato P., LaRussa P., Lee P., Steinberg S., Lungu O., Gershon A.A., and Silverstein S. Evidence of latent varicella-zoster virus in rat dorsal root ganglia. J. Infect. Dis. 178 Suppl. 1 (1998) S48-S51
3. Ashburn C.V., and Gray W.L. Expression of the simian varicella virus glycoprotein L and H. Arch. Virol. 147 2 (2002) 335-348
4. Chen J.J., Wan S.L., Bischoff S.C., Gershon A.A., and Gershon M.D. Infection, latency, and reactivation of varicella zoster virus in enteric neurons: occurrence in human subjects and analysis of art animal model. Gastroenterology 124 4 (2003) A558
5. Cohrs R.J., and Gilden D.H. Prevalence and abundance of latently transcribed varicella-zoster virus genes in human ganglia. J. Virol. 81 6 (2007) 2950-2956
6. Debrus S., Sadzot-Delvaux C., Nikkels A.F., Piette J., and Rentier B. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J. Virol. 69 5 (1995) 3240-3245
7. Heininger U., and Seward J.F. Varicella. Lancet 368 9544 (2006) 1365-1376
8. Kennedy P.G., Grinfeld E., Bontems S., and Sadzot-Delvaux C. Varicella-zoster virus gene expression in latently infected rat dorsal root ganglia. Virology 289 2 (2001) 218-223
9. Kennedy P.G.E., Grinfeld E., Traina-Dorge V., Gilden D.H., and Mahalingam R. Neuronal localization of simian varicella virus DNA in ganglia of naturally infected African green monkeys. Virus Genes 28 3 (2004) 273-276
10. Kolappaswamy K., Mahalingam R., Traina-Dorge V., Shipley S.T., Gilden D.H., Kleinschmidt-DeMasters B.K., McLeod Jr. C.G., Hungerford L.L., and DeTolla L.J. Disseminated simian varicella virus infection in an irradiated rhesus macaque (Macaca mulatta). J. Virol. 81 1 (2007) 411-415
11. Kronenberg A., Bossart W., Wuthrich R.P., Cao C., Lautenschlager S., Wiegand N.D., Mullhaupt B., Noll G., Mueller N.J., and Speck R.F. Retrospective analysis of varicella zoster virus (VZV) copy numbers in plasma of immunocompetent patients with herpes zoster, of immunocompromised patients with disseminated VZV disease, and of asymptomatic solid organ transplant recipients. Transpl. Infect. Dis. 7 3-4 (2005) 116-121
12. LaGuardia J.J., Cohrs R.J., and Gilden D.H. Prevalence of varicella-zoster virus DNA in dissociated human trigeminal ganglion neurons and nonneuronal cells. J. Virol. 73 10 (1999) 8571-8577
13. Levin M.J., Cai G.Y., Manchak M.D., and Pizer L.I. Varicella-zoster virus DNA in cells isolated from human trigeminal ganglia. J. Virol. 77 12 (2003) 6979-6987
14. Ljungman P., Lonnqvist B., Gahrton G., Ringden O., Sundqvist V.A., and Wahren B. Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients. J. Infect. Dis. 153 5 (1986) 840-847
15. Lowry P.W., Sabella C., Koropchak C.M., Watson B.N., Thackray H.M., Abbruzzi G.M., and Arvin A.M. Investigation of the pathogenesis of varicella-zoster virus infection in guinea pigs by using polymerase chain reaction. J. Infect. Dis. 167 1 (1993) 78-83
16. Luby J.P., Ramirez-Ronda C., Rinner S., Hull A., and Vergne-Marini P. A longitudinal study of varicella-zoster virus infections in renal transplant recipients. J. Infect. Dis. 135 4 (1977) 659-663
17. Mahalingam R., Smith D., Wellish M., Wolf W., Dueland A.N., Cohrs R., Soike K., and Gilden D. Simian varicella virus DNA in dorsal root ganglia. Proc. Natl. Acad. Sci. U.S.A. 88 7 (1991) 2750-2752
18. Mahalingam R., Clarke P., Wellish M., Dueland A.N., Soike K.F., Gilden D.H., and Cohrs R. Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia. Virology 188 1 (1992) 193-197
19. Mahalingam R., Wellish M., Cohrs R., Debrus S., Piette J., Rentier B., and Gilden D.H. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc. Natl. Acad. Sci. U.S.A. 93 5 (1996) 2122-2124
20. Mahalingam R., Traina-Dorge V., Wellish M., Smith J., and Gilden D.H. Naturally acquired simian varicella virus infection in African green monkeys. J. Virol. 76 17 (2002) 8548-8550
21. Mandal B.K. Herpes zoster and the immunocompromised. J. Infect. 14 1 (1987) 1-5
22. Matsunaga Y., Yamanishi K., and Takahashi M. Experimental infection and immune response of guinea pigs with varicella-zoster virus. Infect. Immun. 37 2 (1982) 407-412
23. Mehta S.K., Cohrs R.J., Forghani B., Zerbe G., Gilden D.H., and Pierson D.L. Stress-induced subclinical reactivation of varicella zoster virus in astronauts. J. Med. Virol. 72 1 (2004) 174-179
24. Myers M.G., Duer H.L., and Hausler C.K. Experimental infection of guinea pigs with varicella-zoster virus. J. Infect. Dis. 142 3 (1980) 414-420
25. Myers M.G., Stanberry L.R., and Edmond B.J. Varicella-zoster virus infection of strain 2 guinea pigs. J. Infect. Dis. 151 1 (1985) 106-113
26. Quinlivan M., and Breuer J. Molecular studies of varicella zoster virus. Rev. Med. Virol. 16 4 (2006) 225-250
27. Schunemann S., Mainka C., and Wolff M.H. Subclinical reactivation of varicella-zoster virus in immunocompromised and immunocompetent individuals. Intervirology 41 2-3 (1998) 98-102
28. Soike K.F. Simian varicella virus infection in African and Asian monkeys. The potential for development of antivirals for animal diseases. Ann. N. Y. Acad. Sci. 653 (1992) 323-333
29. Soike K.F., Rangan S.R., and Gerone P.J. Viral disease models in primates. Adv. Vet. Sci. Comp. Med. 28 (1984) 151-199
30. Soike K.F., Huang J.L., Zhang J.Y., Bohm R., Hitchcock M.J., and Martin J.C. Evaluation of infrequent dosing regimens with (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine (S-HPMPC) on simian varicella infection in monkeys. Antivir. Res. 16 1 (1991) 17-28
31. Takahashi M., Okuno Y., Otsuka T., Osame J., and Takamizawa A. Development of a live attenuated varicella vaccine. Biken J. 18 1 (1975) 25-33
32. Tenser R.B., and Hyman R.W. Latent herpesvirus infections of neurons in guinea pigs and humans. Yale J. Biol. Med. 60 2 (1987) 159-167
33. Walz-Cicconi M.A., Rose R.M., Dammin G.J., and Weller T.H. Inoculation of guinea pigs with varicella-zoster virus via the respiratory route. Arch. Virol. 88 3-4 (1986) 265-277
34. Weller T.H. The etiological agents of varicella and herpes zoster. Isolation, propagation, and culture characteristics in vitro. J. Exp. Med. 108 6 (1958) 843-868
35. White T.M., Mahalingam R., Traina-Dorge V., and Gilden D.H. Simian varicella virus DNA is present and transcribed months after experimental infection of adult African green monkeys. J. Neurovirol. 8 3 (2002) 191-203
36. Wroblewska Z., Devlin M., Reilly K., van Trieste H., Wellish M., and Gilden D.H. The production of varicella zoster virus antiserum in laboratory animals. Arch. Virol. 74 2-3 (1982) 233-238
37. Wroblewska Z., Valyi-Nagy T., Otte J., Dillner A., Jackson A., Sole D.P., and Fraser N.W. A mouse model for varicella-zoster virus latency. Microb. Pathog. 15 2 (1993) 141-151
38. Zerboni L., Hinchliffe S., Sommer M.H., Ito H., Besser J., Stamatis S., Cheng J., DiStefano D., Kraiouchkine N., Shaw A., and Arvin A.M. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 332 1 (2005) 337-346